AboGen Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $25K
Latest Deal Amount
  • Investors
  • 2

AboGen General Information

Description

Developer of a medical device designed to preserve components of saliva for medical tests. The company's medical device uses a saliva collection and preservation technology to preserve all the components in saliva and replace blood tests performed annually, enabling physicians to reduce blood tests and increase diagnosis accuracy.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
  • 477 Congress Street
  • Suite 1010
  • Portland, ME 04101
  • United States
+1 (207) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AboGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 28-Jul-2017 $25K 00000 Completed Startup
2. Convertible Debt 01-Mar-2015 00000 00000 Completed Startup
1. Debt - General 16-Dec-2013 $430K $430K Completed Startup
To view AboGen’s complete valuation and funding history, request access »

AboGen Executive Team (3)

Name Title Board Seat Contact Info
Michael Steele Chief Business Officer
Stephen Andrews Ph.D Co-Founder, Chief Executive Officer & Board Member
Youssef Biadillah Co-Founder, President, Chief Operating Officer & Board Member
To view AboGen’s complete executive team members history, request access »

AboGen Board Members (5)

Name Representing Role Since
Fred Heimann AboGen Board Member 000 0000
Jacques Essinger AboGen Board Member 000 0000
Ken Martin AboGen Board Member 000 0000
Stephen Andrews Ph.D AboGen Co-Founder, Chief Executive Officer & Board Member 000 0000
Youssef Biadillah Self Co-Founder, President, Chief Operating Officer & Board Member 000 0000
To view AboGen’s complete board members history, request access »

AboGen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AboGen Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Boynton Angels Angel Group 000 0000 000000 0
Maine Angels Angel Group 000 0000 000000 0
To view AboGen’s complete investors history, request access »